Pharmacists as providers of HIV pre-exposure prophylaxis

被引：27
|
作者：
Bruno, Christine [2 ]
Saberi, Parya [1 ]
机构：
[1] Univ Calif San Francisco, San Francisco, CA 94143 USA
[2] Kaiser Permanente, Vallejo, CA USA
来源：
INTERNATIONAL JOURNAL OF CLINICAL PHARMACY | 2012年 / 34卷 / 06期
关键词：
Adherence; HIV/AIDS; Pharmacist Pre-exposure prophylaxis; Prevention; PrEP; DISEASE RISK; IMPACT; CARE; INFECTION; INTERVENTIONS; TRANSMISSION; PREVENTION; ADHERENCE; OUTCOMES; TRIALS;
D O I：
10.1007/s11096-012-9709-0
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
The efficacy of HIV pre-exposure prophylaxis (PrEP) has been demonstrated in four clinical trials to date; however, the success of PrEP is largely dependent on high levels of medication adherence. Due to their extensive experience and expertise in medication adherence counseling, as well as their ability to monitor and manage medication adverse effects and drug-drug interactions, clinical pharmacists are well-equipped to play a key role in effective PrEP utilization. Here we discuss reasons favoring the establishment of a protocol-based, pharmacist-run PrEP clinic.
引用
收藏
页码：803 / 806
页数：4
相关论文
共 50 条
  • [31] PRIMARY CARE PROVIDERS' INFORMATION NEEDS FOR PRESCRIBING ADOLESCENTS HIV PRE-EXPOSURE PROPHYLAXIS
    Owens, Christopher
    Stukenberg, Jacob
    Grant, Morgan J.
    Hoffman, Matt
    [J]. AIDS EDUCATION AND PREVENTION, 2023, 35 (06) : 484 - 494
  • [32] Pre-exposure prophylaxis as HIV prevention in the UK
    Brady, Michael
    [J]. THERAPEUTIC ADVANCES IN CHRONIC DISEASE, 2016, 7 (03) : 150 - 152
  • [33] HIV moments and pre-exposure prophylaxis Reply
    Dunn, David T.
    Gafos, Mitzy
    White, Ellen
    McCormack, Sheena
    [J]. LANCET, 2016, 387 (10027): : 1508 - 1508
  • [34] HIV pre-exposure prophylaxis: effective and underused
    Hempel, Amanda
    Biondi, Mia J.
    Baril, Jean-Guy
    Tan, Darrell H. S.
    [J]. CANADIAN MEDICAL ASSOCIATION JOURNAL, 2022, 194 (45) : E1544 - E1550
  • [35] HIV prevention using pre-exposure prophylaxis
    Daou, S.
    Calmy, A.
    [J]. REVUE DE MEDECINE INTERNE, 2011, 32 (11): : 658 - 662
  • [36] Why Do HIV Pre-Exposure Prophylaxis Users Discontinue Pre-Exposure Prophylaxis Care? A Mixed Methods Survey in a Pre-Exposure Prophylaxis Clinic in Belgium
    Vanbaelen, Thibaut
    Rotsaert, Anke
    Jacobs, Bart K. M.
    Florence, Eric
    Kenyon, Chris
    Vuylsteke, Bea
    Laga, Marie
    Thijs, Reyniers
    [J]. AIDS PATIENT CARE AND STDS, 2022, 36 (04) : 159 - 167
  • [37] Oral pre-exposure prophylaxis for HIV prevention
    Garcia-Lerma, J. Gerardo
    Paxton, Lynn
    Kilmarx, Peter H.
    Heneine, Walid
    [J]. TRENDS IN PHARMACOLOGICAL SCIENCES, 2010, 31 (02) : 74 - 81
  • [38] PrEP: pre-exposure prophylaxis for HIV prevention
    Page, Matthew
    Nicholls, Jane
    [J]. TRENDS IN UROLOGY & MENS HEALTH, 2018, 9 (04) : 22 - 24
  • [39] Pre-Exposure Prophylaxis for HIV: Evidence and Perspectives
    Nikolopoulos, Georgios K.
    Christaki, Eirini
    Paraskevis, Dimitrios
    Bonovas, Stefanos
    [J]. CURRENT PHARMACEUTICAL DESIGN, 2017, 23 (18) : 2579 - 2591
  • [40] Pre-exposure prophylaxis for HIV: effective and underused
    Hempel, Amanda
    Biondi, Mia J.
    Baril, Jean-Guy
    Tan, Darrell H. S.
    [J]. CANADIAN MEDICAL ASSOCIATION JOURNAL, 2022, 194 (34) : E1164 - E1170
12345